Vimarsana
Biggest News Aggregation in the World

Damien Mcdevitt News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Damien Mcdevitt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Damien Mcdevitt Today - Breaking & Trending Today

Aspen Neuroscience to Present at Future of Parkinson's Disease Conference - Vimarsana News

Aspen Neuroscience to Present at Future of Parkinson's Disease Conference

/PRNewswire/ -- This week, Aspen Neuroscience will present to the Parkinson's community at the Future of Parkinson's Disease conference, held November 30 –...

Autologous Neuron Replacement Cell Therapy Fast Tracked for Parkinson Disease - Vimarsana News

Autologous Neuron Replacement Cell Therapy Fast Tracked for Parkinson Disease

The FDA has granted Fast Track designation to ANPD001 to improve motor function in patients with Parkinson disease.

Source: empr.com
Aspen Neuroscience in Torrey Pines Takes on Digital Partners for Parkinson's Study - Vimarsana News

Aspen Neuroscience in Torrey Pines Takes on Digital Partners for Parkinson's Study

Aspen Neuroscience in Torrey Pines has announced a digital partnership with Emerald Innovations and Rune Labs on a study to treat Parkinson's disease.

Aspen Neuroscience to Partner with Rune Labs and Emerald Innovations to Incorporate both Active and Passive Digital Health Monitoring in Trial Ready Cohort Screening Study - Vimarsana News

Aspen Neuroscience to Partner with Rune Labs and Emerald Innovations to Incorporate both Active and Passive Digital Health Monitoring in Trial Ready Cohort Screening Study

/PRNewswire/ -- Aspen Neuroscience today announced that it is partnering with Emerald Innovations, a pioneer in the creation of "invisible" off-body sensors...

Aspen Neuroscience Announces FDA Clearance of Investigational New Drug Application for ANPD001, Autologous Cell Therapy for the Treatment of Parkinson's Disease - Vimarsana News

Aspen Neuroscience Announces FDA Clearance of Investigational New Drug Application for ANPD001, Autologous Cell Therapy for the Treatment of Parkinson's Disease

/PRNewswire/ -- Aspen Neuroscience today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application,...